GLENMARK PHARMACEUTICALS LTD. - Outcome of Board Meeting

Glenmark Pharmaceuticals Ltd has informed BSE that the Operations Committee of the Board of Directors of the Company, at its Meeting held on April 23, 2014 allotted 6,350 shares to the employees of the Company on exercise of options granted to them pursuant to ESOS 2003.